highly significantP < 0.01
This difference was highly significant in comparison with MCS patients ( P < 0.01) and significant in comparison with SMCS patients ( P < 0.05); this allele was not observed among FM/CFS patients ( Table 2 ).
This difference was highly significant in comparison with MCS patients ( P < 0.01) and significant in comparison with SMCS patients ( P < 0.05); this allele was not observed among FM/CFS patients ( Table 2 ).
In this latter group, the most represented genotype was the (CCTTT) 10/12 genotype that showed a significantly higher frequency when compared with MCS patients (20 versus 2.5%; P = 0.0044) and a borderline significant difference when compared with controls (20 versus 6.7%; P = 0.061), while frequencies in SMCS patients and controls were similar (6.3% versus 6.7%, P > 0.05).
Patients with different NOS2 C2087T genotypes showed different nitrite/nitrate levels, even if these differences did not reach statistical significance.